QTR4 patients (red line), i.e., those with tumor tissues expressing either PRMT5 or APE1 at higher levels, were associated with poorer outcomes compared to QTR1 patients (blue line) (Figure 1). The gene discussed is APEX1; the disease is neoplasm.